Product Reports Resources Pricing Login Book a demo

Evolva

Biotech & Life Sciences · Reinach, Switzerland · Founded 2004 · IPO 2005

Provides products that can contribute to health, wellbeing and sensory enjoyment MoreLess

Evolva, founded in 2004, is a Swiss biotechnology company that focuses on the research, development, and commercialization of natural ingredients for a variety of industries.

The company's core business revolves around its proprietary fermentation platform, which allows for the sustainable and scalable production of high-value ingredients that are traditionally sourced from plants or animals. This approach offers an alternative to synthetic ingredients and addresses the growing consumer demand for natural and sustainable products.

Evolva serves a broad range of markets, including the food and beverage, flavor and fragrance, and health and wellness sectors. Its product portfolio includes ingredients like nootkatone (a citrus flavor and fragrance), resveratrol (a polyphenol with antioxidant properties), and vanillin (a key component of vanilla flavor). The company collaborates with other businesses to develop and commercialize new ingredients, leveraging its technology platform to create customized solutions.

The business model is based on a combination of product sales, milestone payments from collaborations, and royalties on the sales of products containing its ingredients. By offering a sustainable and cost-effective production method, Evolva aims to capture a significant share of the growing market for natural ingredients.

Keywords: biotechnology, natural ingredients, fermentation, sustainable production, food and beverage, flavor and fragrance, health and wellness, nootkatone, resveratrol, vanillin

Valuation $10M
Total funding $10–50M

Talent graph

Evolva's talent

Book a demo to see the people
Team profiled 31 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on Evolva's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Andrea Jansen
Dario Fazlic
Adrian Bührer
US Centers for Disease Control and Prevention
Series A 2 investors entered at this stage
Aravis Ventures
Novartis Venture Fund
Series B+ 8 investors entered at this stage
Heartcore Capital
Vinci Capital
Auriga Partners
Swisscom Ventures
Wellington Partners
BioMedVC
Entrepreneurs Fund
Nice&Green SA

Global footprint

Where Evolva has talent and traffic

Workforce by country
3 countries with
team presence
🇨🇭 Switzerland50%
🇪🇸 Spain5.6%
🇬🇧 United Kingdom5.6%
3 countries shown

Market sentiment

What the market is saying about Evolva

An AI-synthesized read of the highest-engagement posts about Evolva on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Evolva on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.